Management Board
(represented by: Fresenius Medical Care Management AG,
general partner of Fresenius Medical Care AG & Co. KGaA)
From Left to Right:
Dr. Rainer Runte, Mats Wahlstrom, Dr. Ben J. Lipps, Lawrence A. Rosen,
Dr. Emanuele Gatti, Roberto Fusté, Rice Powell
Dr. Ben J. Lipps
Chairman of the Management Board
Dr. Ben J. Lipps (68) was appointed Chief Executive Officer and Chairman of the Management Board of Fresenius Medical Care in 1999. Prior to that, he was CEO of Fresenius Medical Care North America from 1996 to 1999 and of Fresenius USA from 1985 to 1996. Ben Lipps has worked in the field of dialysis for about 40 years. After earning his master’s and doctoral degrees in chemical Engineering at the Massachusetts Institute of Technology, he led the research team at DOW Chemical that developed the first commercial hollow-fiber artificial kidney at the end of the 1960s.
Lawrence A. Rosen
Finances
Lawrence A. Rosen (51) joined Fresenius Medical Care in November 2003 as Chief Financial Officer. Prior to that, he worked for Aventis S.A. in Strasbourg, France, and one of its predecessor companies, Hoechst AG for almost 20 years. His most recent position there was Group Senior Vice President for Corporate Finance and Treasury. Lawrence Rosen holds a Bachelor of Science in Economics from the State University of New York at Brockport and an MBA from the University of Michigan.
Roberto Fusté
Region Asia-Pacific
Roberto Fusté (57) is Chief Executive Officer for Asia-Pacific. After completing his degree in Economic Sciences at the University of Valencia, the Spaniard founded the company Nephrocontrol S.A. in 1983. Nephrocontrol was acquired by the Fresenius Group in 1991, where Mr. Fusté has worked since. Before being appointed to the Management Board of Fresenius Medical Care in 1999, Mr. Fusté held several senior positions within the Company in the Latin America and Asia-Pacific regions.
Dr. Emanuele Gatti
Region Europe, Latin America, Middle East and Africa
Dr. Emanuele Gatti (53) is is Chief Executive Officer for Europe, Latin America, Middle East, and Africa. After completing his studies in bioengineering, Dr. Gatti lectured at several biomedical institutions in Milan. He continues to be involved in comprehensive research and development activities. At present he is Visiting Professor and Chairman of the University Board at the Danube University in Krems, Austria. Dr. Gatti has been with the company since 1989. Before being appointed to the Management Board of Fresenius Medical Care in 1997, he was responsible for the dialysis business in Southern Europe.
Mats Wahlstrom
Dialysis Services North America
Mats Wahlstrom (54) was appointed Member of the Management Board in early 2004. He is also CO-CEO of Fresenius Medical Care North America and CEO of Fresenius Medical Services. Mats Wahlstrom looks back on 26 years of experience in the healthcare industry and has worked in the renal field for 23 years. Prior to joining Fresenius Medical Care in 2002, he held various positions, for example at Gambro AB in Sweden, including President and CEO of Gambro U.S. as well as CFO of the Gambro Group.
Rice Powell
Renal Therapies Group North America
Rice Powell (54) is CEO of the Renal Therapies Group of Fresenius Medical Care in North America. He joined Fresenius Medical Care in 1997 and was appointed CO-CEO of the Company and Member of the Management Board of Fresenius Medical Care North America in January 2004. Rice Powell has 30 years of experience in the healthcare industry. From 1978 to 1996 he held various positions, among others at Baxter International Inc., Biogen Inc., and Ergo Sciences Inc. in the U.S.
Dr. Rainer Runte
Law & Compliance
Dr. Rainer Runte (49) is Member of the Management Board for Law & Compliance at Fresenius Medical Care and has been working for the Fresenius Group for 18 years already. In 1997, he assumed the position of Senior Vice President for Law at Fresenius Medical Care and was appointed to the Management Board in 2002. Prior to that, Rainer Runte worked as a scientific assistant in the law department of the Johann Wolfgang Goethe University in Frankfurt and as an attorney in a firm specialized in economic law.
top